Complex High-Risk Interventional Procedures (CHIP) & Chronic Total Occlusion (CTO) Program
The Yale Complex High-Risk Interventional Procedures (CHIP) & Chronic Total Occlusion (CTO) Program specializes in treating patients with complex coronary artery disease.
Patients with complex coronary disease, chronic total occlusions, and other significant co-morbidities often have limited treatment options. Many are not candidates for revascularization with traditional percutaneous techniques or open-heart surgery. Our program is able to offer nonsurgical interventional solutions for these patients.
Our Team
Our multidisciplinary care team includes world-class interventional cardiologists, cardiothoracic surgeons, heart imaging specialists, and anesthesiologists. We have specialists who have undertaken specific, dedicated training—our team performs more complex coronary interventions annually than any other hospital in Connecticut and is nationally recognized as a leading center for complex coronary interventions.
Our Approach
The Yale Complex High-Risk Interventional Procedures (CHIP) & Chronic Total Occlusion (CTO) Program provides comprehensive management of complex coronary disease using the latest treatment modalities. We use a variety of innovative technologies and techniques to optimize success, safety, and clinical outcomes. Procedures are performed with advanced imaging systems, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT).
Our Services
Our comprehensive treatment options for complex coronary artery disease include:
- Chronic total occlusions (CTO) percutaneous coronary intervention using both antegrade and retrograde techniques
- Atherectomy, including rotational, orbital, and laser
- Bifurcation and trifurcation interventions
- Brachytherapy for coronary artery stent restenosis. Yale New Haven Hospital has the only coronary brachytherapy program in Connecticut and one of the largest in the country.
- Intravascular lithotripsy with shockwave
- Left main interventions
- Protected percutaneous coronary intervention (PCI) using cardiac support with Impella®